Peter M Haddad

Summary

Affiliation: University of Manchester
Country: UK

Publications

  1. ncbi Adverse effects of atypical antipsychotics : differential risk and clinical implications
    Peter M Haddad
    Cromwell House Community Mental Health Centre, Manchester, England
    CNS Drugs 21:911-36. 2007
  2. ncbi What works in schizophrenia: depot preparations may improve outcomes
    Peter M Haddad
    BMJ 333:353. 2006
  3. ncbi Neurological complications of psychiatric drugs: clinical features and management
    Peter M Haddad
    Neuroscience and Psychiatry Unit, School of Psychiatry and Behavioural Sciences, University of Manchester, Manchester, UK
    Hum Psychopharmacol 23:15-26. 2008
  4. ncbi Antipsychotic-related QTc prolongation, torsade de pointes and sudden death
    Peter M Haddad
    Bolton, Salford and Trafford Mental Health Partnership, Eccles, Salford, UK
    Drugs 62:1649-71. 2002
  5. ncbi Antipsychotics and diabetes: review of non-prospective data
    Peter M Haddad
    Cromwell House, Bolton, Salford and Trafford Mental Health NHS Trust, Cromwell Road, Eccles, Salford M30 0GT, UK
    Br J Psychiatry Suppl 47:S80-6. 2004
  6. ncbi Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management
    Peter M Haddad
    Bolton, Salford and Trafford Mental Health NHS Trust, Salford, UK
    Drugs 64:2291-314. 2004
  7. ncbi Adverse effects of antipsychotics as outcome measures
    Samantha Hamer
    Bolton, Salford and Trafford Mental Health NHS Trust, UK
    Br J Psychiatry Suppl 50:s64-70. 2007
  8. ncbi Improving drug safety and tolerability in psychiatric clinical practice
    Peter M Haddad
    Consultant Psychiatrist, Bolton Salford and Trafford Mental Health NHS Trust, UK
    Hum Psychopharmacol 23:S1-2. 2008

Collaborators

Detail Information

Publications8

  1. ncbi Adverse effects of atypical antipsychotics : differential risk and clinical implications
    Peter M Haddad
    Cromwell House Community Mental Health Centre, Manchester, England
    CNS Drugs 21:911-36. 2007
    ..Selection of an antipsychotic should be on an individual patient basis. Patients should be involved in prescribing decisions and this should involve discussion about adverse effects...
  2. ncbi What works in schizophrenia: depot preparations may improve outcomes
    Peter M Haddad
    BMJ 333:353. 2006
  3. ncbi Neurological complications of psychiatric drugs: clinical features and management
    Peter M Haddad
    Neuroscience and Psychiatry Unit, School of Psychiatry and Behavioural Sciences, University of Manchester, Manchester, UK
    Hum Psychopharmacol 23:15-26. 2008
    ..Their occurrence needs to be balanced against the benefits of psychiatric drugs in terms of efficacy and improved quality of life in a range of disorders...
  4. ncbi Antipsychotic-related QTc prolongation, torsade de pointes and sudden death
    Peter M Haddad
    Bolton, Salford and Trafford Mental Health Partnership, Eccles, Salford, UK
    Drugs 62:1649-71. 2002
    ..It seems prudent, where possible, to select antipsychotics that are not associated with marked QTc prolongation. If use of a QTc-prolonging drug is warranted, then measures to reduce the risk should be adopted...
  5. ncbi Antipsychotics and diabetes: review of non-prospective data
    Peter M Haddad
    Cromwell House, Bolton, Salford and Trafford Mental Health NHS Trust, Cromwell Road, Eccles, Salford M30 0GT, UK
    Br J Psychiatry Suppl 47:S80-6. 2004
    ..CONCLUSIONS: Retrospective data are of limited value. Well-designed prospective studies, which account for potential confounders, are needed to investigate the true association between antipsychotic medications and diabetes...
  6. ncbi Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management
    Peter M Haddad
    Bolton, Salford and Trafford Mental Health NHS Trust, Salford, UK
    Drugs 64:2291-314. 2004
    ..Appropriate investigations and effective management should reduce the burden of adverse effects and prevent long-term consequences...
  7. ncbi Adverse effects of antipsychotics as outcome measures
    Samantha Hamer
    Bolton, Salford and Trafford Mental Health NHS Trust, UK
    Br J Psychiatry Suppl 50:s64-70. 2007
    ..Antipsychotic drugs are associated with adverse effects that can lead to poor medication adherence, stigma, distress and impaired quality of life...
  8. ncbi Improving drug safety and tolerability in psychiatric clinical practice
    Peter M Haddad
    Consultant Psychiatrist, Bolton Salford and Trafford Mental Health NHS Trust, UK
    Hum Psychopharmacol 23:S1-2. 2008